Reward O
activation O
in O
childhood O
predicts O
adolescent O
substance O
use O
initiation O
in O
a O
high-risk O
sample O
* O
Background O
Substance O
use O
at O
an O
early O
age O
conveys O
substantial O
risk O
for O
later O
substance-related O
problems O
. O

A O
better O
understanding O
of O
early O
risk O
factors O
could O
result O
in O
more O
timely O
and O
effective O
intervention O
. O

This O
study O
investigated O
the O
predictive O
utility O
of O
the O
brain O
’ O
s O
response O
to O
reward O
anticipation O
as O
a O
risk O
factor O
for O
early O
substance O
use O
initiation O
. O

Methods O
Participants O
were O
34 O
children O
( O
25 O
male O
) O
at O
high O
risk O
for O
alcohol O
and O
other O
substance O
use O
disorders O
from O
a O
longitudinal O
functional O
magnetic O
resonance O
imaging O
study O
, O
scanned O
at O
a O
mean O
age O
of O
10.5 O
years O
( O
SD O
= O
1.2 O
) O
when O
participants O
were O
substance-naïve O
. O

We O
used O
a O
monetary O
incentive O
delay O
task O
to O
examine O
the O
hemodynamic O
response O
of O
the O
nucleus O
accumbens O
to O
gain O
and O
loss O
anticipation O
. O

Logistic O
regression O
was O
used O
to O
test O
the O
hypothesis O
that O
these O
brain O
response O
patterns O
would O
have O
predictive O
utility O
over O
and O
above O
early O
externalizing O
behaviors O
and O
family O
history O
of O
substance O
use O
disorder O
, O
two O
key O
risk O
factors O
for O
substance O
use O
problems O
, O
in O
differentiating O
those O
who O
initiated O
substance O
use O
before O
age O
16 O
( O
n O
= O
18 O
) O
and O
those O
who O
did O
not O
( O
n O
= O
16 O
) O
. O

Results O
Greater O
nucleus O
accumbens O
activation O
during O
monetary O
gain O
anticipation O
in O
childhood O
increased O
the O
likelihood O
of O
initiating O
substance O
use O
during O
early O
adolescence O
( O
p O
= O
.023 O
) O
. O

The O
model O
that O
comprised O
neural O
data O
in O
addition O
to O
early O
externalizing O
behaviors O
and O
family O
history O
showed O
significantly O
better O
fit O
than O
the O
model O
without O
neural O
data O
( O
χ22 O
= O
7.38 O
, O
p O
= O
.025 O
) O
. O

Conclusions O
Heightened O
gain O
anticipation O
activation O
in O
the O
nucleus O
accumbens O
may O
predispose O
individuals O
to O
early O
substance O
use O
, O
beyond O
the O
risk O
conveyed O
by O
other O
known O
factors O
. O

Material O
and O
Methods O
Participants O
Participants O
were O
34 O
youth O
( O
25 O
male O
) O
from O
the O
MLS O
, O
aged O
8.2–12.9 O
at O
the O
time O
of O
the O
fMRI O
scan O
( O
M O
= O
10.5 O
, O
SD O
= O
1.2 O
) O
. O

The O
MLS O
is O
a O
multi-wave O
, O
community-recruited O
study O
of O
families O
with O
and O
without O
parental O
alcohol O
use O
disorder O
( O
AUD O
) O
. O

As O
part O
of O
the O
MLS O
, O
assessments O
were O
conducted O
every O
three O
years O
starting O
when O
the O
children O
were O
aged O
3–5 O
; O
adolescents O
and O
young O
adults O
were O
also O
assessed O
every O
year O
from O
age O
11–26 O
. O

Families O
were O
excluded O
if O
the O
target O
child O
displayed O
evidence O
of O
fetal O
alcohol O
effects O
or O
the O
mother O
reported O
drinking O
during O
pregnancy O
. O

The O
majority O
of O
participants O
in O
the O
present O
analyses O
( O
82.4 O
% O
) O
were O
FH+ O
for O
SUD O
, O
making O
this O
a O
high-risk O
sample O
. O

( O
Although O
the O
original O
recruitment O
strategy O
of O
the O
MLS O
involved O
accessing O
a O
community-based O
sample O
of O
parents O
with O
AUD O
, O
their O
high O
other O
drug O
comorbidity O
meant O
that O
their O
offspring O
would O
be O
at O
elevated O
risk O
for O
both O
alcohol O
and O
other O
drug O
use O
. O

The O
MLS O
has O
historically O
focused O
on O
understanding O
these O
other O
risk O
patterns O
as O
well O
) O
Full O
details O
on O
MLS O
assessment O
and O
data O
collection O
can O
be O
found O
elsewhere O
. O

For O
the O
present O
imaging O
study O
, O
participants O
were O
excluded O
if O
they O
had O
any O
neurological O
, O
acute O
, O
uncorrected O
, O
or O
chronic O
medical O
illness O
; O
current O
or O
recent O
( O
within O
6 O
months O
) O
treatment O
with O
centrally O
active O
medications O
; O
MRI O
contraindications O
such O
as O
metal O
implants O
or O
claustrophobia O
; O
IQ O
< O
70 O
; O
history O
of O
psychosis O
in O
self O
or O
first-degree O
relatives O
; O
or O
current O
, O
active O
Axis O
I O
disorder O
according O
to O
the O
Diagnostic O
and O
Statistical O
Manual O
of O
Mental O
Disorders O
( O
DSM-IV O
) O
criteria O
. O

However O
, O
disorders O
that O
are O
often O
comorbid O
with O
substance O
use O
were O
not O
part O
of O
the O
exclusion O
criteria O
( O
so O
as O
not O
to O
bias O
the O
sample O
against O
our O
construct O
of O
interest O
) O
: O
current O
or O
past O
anxiety O
, O
conduct O
or O
attention O
deficit O
hyperactivity O
( O
ADHD O
) O
disorder O
, O
or O
past O
mood O
disorder O
. O

Participants O
who O
were O
taking O
medication O
for O
ADHD O
were O
asked O
to O
abstain O
at O
least O
48 O
hours O
before O
the O
MRI O
scan O
. O

Parents/guardians O
of O
participants O
provided O
written O
informed O
consent O
and O
participants O
provided O
written O
informed O
assent O
. O

Study O
materials O
and O
procedures O
were O
approved O
by O
the O
University O
of O
Michigan O
Medical O
School O
Institutional O
Review O
Board O
. O

Measures O
Substance O
use O
Drinking O
and O
drug O
use O
histories O
were O
obtained O
from O
each O
participant O
by O
trained O
research O
staff O
as O
part O
of O
the O
regular O
MLS O
assessment O
schedule O
. O

Beginning O
at O
age O
6 O
and O
occurring O
at O
three-year O
intervals O
thereafter O
, O
a O
health O
and O
daily O
living O
questionnaire O
was O
used O
to O
assess O
the O
use O
of O
alcohol O
( O
more O
than O
a O
sip O
) O
, O
cigarettes O
, O
marijuana O
, O
and O
other O
drugs O
. O

If O
applicable O
, O
the O
age O
at O
which O
use O
occurred O
and O
the O
quantity/frequency O
of O
use O
was O
also O
recorded O
. O

At O
annual O
assessments O
beginning O
at O
age O
11 O
, O
the O
Drinking O
and O
Drug O
History O
Form O
for O
Children O
was O
used O
to O
assess O
the O
quantity O
and O
frequency O
of O
alcohol O
, O
nicotine O
, O
and O
illicit O
drug O
( O
i.e. O
, O
marijuana O
and O
17 O
other O
drugs O
, O
including O
inhalants O
and O
prescription O
drugs O
used O
non-medically O
) O
use O
. O

Problems O
associated O
with O
alcohol O
and O
drug O
use O
, O
respectively O
( O
e.g. O
, O
missed O
school O
because O
of O
drinking O
, O
had O
trouble O
getting O
along O
with O
friends O
because O
of O
drug O
use O
) O
, O
were O
also O
assessed O
. O

Previous O
research O
has O
shown O
that O
substance O
use O
initiation O
before O
the O
age O
of O
16 O
confers O
a O
higher O
risk O
for O
later O
problems O
than O
does O
initiation O
in O
young O
adulthood O
. O

Therefore O
, O
we O
used O
age O
16 O
as O
the O
threshold O
for O
increased O
risk O
and O
selected O
participants O
from O
the O
ongoing O
longitudinal O
study O
for O
whom O
we O
had O
follow-up O
substance O
use O
data O
at O
age O
16 O
or O
older O
( O
ensuring O
that O
all O
comparison O
participants O
were O
beyond O
the O
highest-risk O
window O
) O
. O

Participants O
also O
had O
to O
have O
a O
fMRI O
scan O
prior O
to O
any O
substance O
use O
in O
order O
to O
be O
included O
in O
the O
present O
analyses O
. O

Of O
the O
34 O
participants O
who O
met O
these O
criteria O
, O
18 O
eventually O
initiated O
substance O
use O
( O
11 O
male O
; O
initiation O
group O
) O
, O
whereas O
16 O
did O
not O
( O
14 O
male O
; O
comparison O
group O
) O
. O

On O
average O
, O
those O
in O
the O
comparison O
group O
were O
17.9 O
years O
old O
( O
SD O
1.5 O
) O
at O
the O
most O
recent O
substance O
use O
assessment O
, O
whereas O
those O
in O
the O
initiation O
group O
were O
13.4 O
years O
old O
( O
SD O
1.5 O
) O
at O
substance O
use O
initiation O
. O

Other O
measures O
The O
Wechsler O
Intelligence O
Scale O
for O
Children O
( O
WISC-III O
) O
was O
used O
to O
assess O
full-scale O
IQ O
. O

Early O
externalizing O
behaviors O
( O
M O
= O
7.4 O
years O
old O
, O
SD O
= O
1.0 O
) O
were O
assessed O
via O
parent-report O
with O
T-scores O
from O
the O
Child O
Behavior O
Checklist O
( O
CBCL O
) O
. O

For O
ADHD O
, O
conduct O
disorder O
, O
depression O
, O
and O
anxiety O
diagnoses O
( O
i.e. O
, O
disorders O
that O
were O
not O
exclusionary O
during O
screening O
) O
, O
the O
computerized O
Diagnostic O
Interview O
Schedule O
for O
Children O
( O
C-DISC O
) O
was O
given O
, O
and O
diagnoses O
were O
tallied O
based O
on O
DSM-IV O
criteria O
. O

Finally O
, O
FH O
was O
defined O
as O
the O
number O
of O
parents O
( O
0 O
, O
1 O
, O
or O
2 O
) O
with O
a O
lifetime O
diagnosis O
of O
drug O
or O
alcohol O
abuse O
or O
dependence O
, O
according O
to O
DSM-IV O
criteria O
. O

Stimuli O
and O
Task O
A O
modified O
MID O
task O
was O
used O
to O
probe O
the O
brain O
’ O
s O
response O
to O
the O
anticipation O
of O
monetary O
incentive O
( O
i.e. O
, O
gain O
and O
loss O
) O
. O

Each O
trial O
was O
6-s O
long O
and O
consisted O
of O
4 O
stimuli O
, O
presented O
consecutively O
: O
1 O
) O
2000-ms O
incentive O
cue O
( O
“ O
Win O
$ O
5.00 O
, O
” O
“ O
Win O
$ O
0.20 O
, O
” O
“ O
Don O
’ O
t O
Lose O
$ O
5.00 O
, O
” O
“ O
Don O
’ O
t O
Lose O
$ O
0.20 O
, O
” O
or O
“ O
No O
Money O
at O
Stake O
” O
) O
, O
2 O
) O
2000-ms O
anticipation O
fixation O
cross O
, O
3 O
) O
variable-duration O
response O
target O
( O
i.e. O
, O
a O
solid O
black O
shape O
cuing O
a O
button O
press O
) O
, O
and O
4 O
) O
variable-duration O
feedback O
( O
e.g. O
, O
“ O
Correct O
Response O
. O

You O
earn O
$ O
5.00 O
! O
” O
) O
. O

There O
was O
no O
inter-trial O
interval O
. O

Participants O
were O
instructed O
to O
press O
the O
button O
to O
the O
target O
; O
responding O
while O
the O
target O
was O
on O
the O
screen O
signified O
a O
successful O
trial O
( O
i.e. O
, O
hit O
) O
. O

Response O
target O
duration O
was O
calculated O
based O
on O
each O
participant O
’ O
s O
reaction O
time O
during O
a O
practice O
session O
prior O
to O
scanning O
and O
recalibrated O
after O
the O
first O
run O
for O
an O
overall O
success O
rate O
of O
approximately O
60 O
% O
. O

Participants O
were O
also O
instructed O
to O
respond O
to O
neutral O
targets O
( O
i.e. O
, O
“ O
No O
Money O
at O
Stake O
” O
) O
despite O
no O
incentive O
value O
. O

Trials O
were O
presented O
in O
pseudorandom O
order O
in O
two O
5-minute O
runs O
of O
20 O
gain O
trials O
, O
20 O
loss O
trials O
, O
and O
10-neutral O
trials O
per O
run O
. O

Participants O
were O
paid O
money O
won O
during O
the O
task O
. O

fMRI O
Data O
Acquisition O
Whole-brain O
BOLD O
, O
functional O
images O
were O
acquired O
on O
a O
3.0T O
GE O
MR750 O
scanner O
( O
Milwaukee O
, O
WI O
) O
using O
T2 O
* O
-weighted O
single-shot O
combined O
spiral O
in/out O
sequences O
( O
TR O
2000 O
ms O
, O
TE O
30 O
ms O
, O
flip O
angle O
90 O
degrees O
, O
field-of-view O
200 O
mm O
, O
matrix O
size O
64 O
× O
64 O
, O
slice O
thickness O
4 O
mm O
, O
in-plane O
resolution O
3.12 O
× O
3.12 O
mm O
, O
29 O
slices O
) O
. O

High-resolution O
anatomical O
T1 O
scans O
were O
also O
obtained O
for O
spatial O
normalization O
( O
TR O
12.2 O
ms O
, O
TE O
5.2 O
ms O
, O
flip O
angle O
15 O
degrees O
, O
field-of-view O
26 O
mm O
, O
matrix O
size O
256 O
× O
192 O
, O
slice O
thickness O
1.2 O
mm O
, O
in-plane O
resolution O
1.02 O
× O
1.08 O
mm O
, O
124 O
slices O
) O
. O

Motion O
was O
minimized O
with O
foam O
padding O
around O
the O
head O
and O
instructing O
participants O
on O
the O
importance O
of O
keeping O
still O
. O

Data O
processing O
and O
analytic O
strategy O
Preprocessing O
Functional O
images O
were O
reconstructed O
using O
an O
iterative O
algorithm O
and O
motion O
corrected O
using O
FSL O
v5.0.2.2 O
( O
FMRIB O
, O
Oxford O
, O
UK O
) O
. O

Runs O
exceeding O
3 O
mm O
translation O
or O
3° O
rotation O
were O
excluded O
. O

The O
difference O
between O
initiation O
and O
comparison O
groups O
on O
the O
number O
of O
runs O
excluded O
was O
not O
significant O
: O
initiation O
= O
16.7 O
% O
, O
comparison O
= O
15.6 O
% O
, O
t O
( O
32 O
) O
= O
0.13 O
, O
p O
= O
.901 O
. O

Image O
preprocessing O
was O
completed O
using O
Statistical O
Parametric O
Mapping O
( O
SPM8 O
; O
Wellcome O
Institute O
of O
Cognitive O
Neurology O
, O
Oxford O
, O
UK O
) O
. O

Functional O
images O
were O
slice-time O
corrected O
, O
spatially O
normalized O
to O
the O
Montreal O
Neurological O
Institute O
( O
MNI O
) O
template O
using O
SPM8 O
defaults O
, O
and O
smoothed O
with O
a O
6-mm O
full-width O
at O
half-maximum O
( O
FWHM O
) O
smoothing O
kernel O
. O

Low-frequency O
noise O
was O
removed O
with O
a O
high-pass O
filter O
( O
128 O
sec O
) O
. O

Individual-level O
analyses O
Image O
processing O
was O
done O
in O
SPM8 O
, O
and O
individual-level O
analyses O
were O
carried O
out O
using O
the O
general O
linear O
model O
. O

Two O
general O
events O
were O
modeled O
: O
1 O
) O
incentive O
cue O
+ O
anticipation O
fixation O
, O
and O
2 O
) O
response O
target O
+ O
feedback O
. O

The O
incentive O
cue O
+ O
anticipation O
fixation O
event O
was O
modeled O
separately O
for O
each O
cue O
type O
: O
large O
gain O
, O
small O
gain O
, O
large O
loss O
, O
small O
loss O
, O
and O
neutral O
. O

The O
response O
+ O
feedback O
event O
was O
modeled O
separately O
for O
each O
cue O
( O
except O
neutral O
) O
and O
feedback O
type O
: O
positive O
( O
i.e. O
, O
hit O
) O
and O
negative O
( O
i.e. O
, O
miss O
) O
for O
each O
of O
large O
gain O
, O
small O
gain O
, O
large O
loss O
, O
and O
small O
loss O
. O

These O
were O
convolved O
with O
the O
standard O
hemodynamic O
response O
function O
, O
along O
with O
six O
realignment O
parameters O
and O
white O
matter O
signal O
intensity O
as O
nuisance O
variables O
. O

Owing O
to O
our O
focus O
in O
this O
study O
on O
NAcc O
activation O
during O
the O
anticipation O
of O
gaining O
and O
losing O
money O
, O
NAcc O
spherical O
anatomical O
masks O
of O
5 O
mm O
in O
diameter O
and O
centered O
on O
the O
Montreal O
Neurological O
Institute O
coordinates O
of O
[ O
x O
= O
−10 O
, O
y O
= O
13 O
, O
z O
= O
−8 O
] O
and O
[ O
x O
= O
10 O
, O
y O
= O
13 O
, O
z O
= O
−8 O
] O
were O
used O
to O
extract O
mean O
parameter O
estimates O
with O
MarsBaR O
for O
two O
contrasts O
of O
interest O
: O
large O
gain O
anticipation O
vs. O
neutral O
anticipation O
( O
i.e. O
, O
Win O
$ O
5.00 O
vs. O
No O
Money O
at O
Stake O
) O
and O
large O
loss O
anticipation O
vs. O
neutral O
anticipation O
( O
i.e. O
, O
Don O
’ O
t O
Lose O
$ O
5.00 O
vs. O
No O
Money O
at O
Stake O
) O
. O

This O
task O
was O
originally O
developed O
with O
different O
incentive O
values O
so O
that O
the O
parametric O
effect O
of O
different O
monetary O
amounts O
could O
be O
investigated O
. O

Our O
interest O
here O
was O
in O
the O
function O
of O
reward O
processing O
overall O
rather O
than O
the O
difference O
between O
large O
and O
small O
incentives O
, O
and O
previous O
work O
has O
found O
that O
large O
incentives O
elicit O
a O
more O
robust O
signal O
than O
do O
small O
incentives O
. O

Thus O
, O
we O
focused O
on O
large O
gain O
and O
loss O
for O
the O
present O
analyses O
. O

After O
extraction O
, O
comparisons O
of O
the O
left O
and O
right O
NAcc O
using O
paired O
samples O
t-tests O
( O
large O
gain O
: O
t O
( O
33 O
) O
=0.94 O
, O
p=.353 O
; O
large O
loss O
: O
t O
( O
33 O
) O
=0.09 O
, O
p=.928 O
) O
and O
correlational O
analyses O
( O
large O
gain O
: O
r=.84 O
, O
p O
< O
.001 O
; O
large O
loss O
: O
r=.73 O
, O
p O
< O
.001 O
) O
indicated O
that O
a O
single O
averaged O
left/right O
NAcc O
variable O
for O
each O
of O
the O
two O
contrasts O
of O
interest O
could O
be O
used O
. O

Prediction O
of O
substance O
use O
initiation O
using O
logistic O
regression O
Hierarchical O
logistic O
regression O
was O
used O
to O
test O
the O
predictive O
utility O
of O
substance O
use O
risk O
factors O
on O
the O
initiation O
of O
substance O
use O
by O
age O
16 O
. O

Group O
membership O
( O
initiation O
or O
comparison O
) O
was O
the O
dependent O
variable O
. O

Phenotypic O
variables O
( O
externalizing O
behaviors O
[ O
continuous O
variable O
] O
and O
FH O
[ O
i.e. O
, O
0 O
, O
1 O
, O
or O
2 O
parents O
] O
) O
were O
entered O
as O
predictors O
in O
the O
first O
block O
( O
restricted O
model O
) O
. O

NAcc O
variables O
( O
large O
gain O
anticipation O
and O
large O
loss O
anticipation O
[ O
continuous O
variables O
] O
) O
were O
added O
in O
the O
second O
block O
( O
full O
model O
) O
. O

No O
other O
covariates O
were O
included O
in O
either O
block O
. O

Model O
comparison O
was O
performed O
using O
a O
likelihood O
ratio O
test O
to O
determine O
whether O
the O
full O
model O
( O
i.e. O
, O
phenotypic O
and O
NAcc O
variables O
) O
showed O
a O
significantly O
better O
fit O
than O
the O
restricted O
model O
( O
i.e. O
, O
phenotypic O
variables O
alone O
) O
. O

In O
addition O
, O
beta O
coefficients O
were O
individually O
tested O
for O
significance O
. O

Alpha O
was O
set O
at O
.05 O
for O
both O
of O
these O
analyses O
. O

Demographic O
, O
Psychometric O
, O
and O
Task O
Performance O
Measures O
Independent O
samples O
t-tests O
or O
Fisher O
’ O
s O
exact O
tests O
were O
used O
to O
evaluate O
differences O
between O
initiation O
and O
comparison O
groups O
on O
demographic O
, O
psychometric O
, O
and O
task O
performance O
measures O
. O

